Adakveo 100 mg/10 mL (10 mg/mL) injection Images
Generic Name: crizanlizumab
This medication has been identified as Adakveo 100 mg/10 mL (10 mg/mL) injection. It is supplied by Novartis Pharmaceuticals Corporation.
Adakveo is used in the treatment of Sickle Cell Anemia and belongs to the drug class miscellaneous uncategorized agents. Adakveo 100 mg/10 mL (10 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Adakveo
- Generic Name
- crizanlizumab
- Strength
- 100 mg/10 mL (10 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- Miscellaneous uncategorized agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals Corporation
- National Drug Code (NDC)
- 00078-0883
See also:
Hydrea
Hydrea is used for chronic myelogenous leukemia, head and neck cancer
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Aquasol E
Aquasol E is used for alzheimer's disease, cystic fibrosis, dietary supplementation, nocturnal leg ...
Xromi
Xromi (hydroxyurea) is an oral solution that may be used to reduce the frequency of painful crises ...
More about Adakveo (crizanlizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous uncategorized agents
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.